Biologics Allosource’s Cartilage Allograft Expertise to be Featured at the International Cartilage Regeneration & Joint Preservation Society Annual Meeting byChris StewartApril 5, 2022
Extremities Spine Sports Medicine UAT Group Subsidiary, Ossifix Orthopedics, Begins Production of Fixation Pin, Significant Sales Expected byChris StewartFebruary 14, 2022
Biologics Financial MTF Biologics Awards More Than $1 Million in 2021 Research Grants to Support Allograft Research byChris StewartFebruary 9, 2022
Biologics Extremities AlloSource Launches Allomend Extra-large Acellular Dermal Matrix byJosh SandbergOctober 27, 2021
Biologics Top Stories AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix byJosh SandbergAugust 11, 2021
Biologics Extremities Spine Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide byJosh SandbergJuly 13, 2021
Biologics Spine Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™ byJosh SandbergFebruary 19, 2021
Biologics Extremities ViviGen® Cellular Bone Matrix outperforms MSC-based allografts and is equivalent to gold standard autograft byChris StewartDecember 29, 2020
Biologics Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research byChris StewartDecember 8, 2020
Biologics Spine SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS) byChris StewartNovember 3, 2020